In addition to molecular processes that are altered in response to hypoxia and which provide new information about chondrosarcoma progression, we identified a number of proteins, including GAPDH, that may be further developed as predictive and/or prognostic biomarkers for chondrosarcoma. Here, GAPDH is linked to chondrosarcoma.